Canafarma Hemp Products Stock Performance
| CNFHF Stock | USD 0.0001 0.00 0.00% |
The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and CanaFarma Hemp are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days CanaFarma Hemp Products has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical indicators, CanaFarma Hemp is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 1.3 M | |
| Total Cashflows From Investing Activities | -659.4 K | |
| Free Cash Flow | -6.7 M |
CanaFarma |
CanaFarma Hemp Relative Risk vs. Return Landscape
If you would invest 0.01 in CanaFarma Hemp Products on September 29, 2025 and sell it today you would earn a total of 0.00 from holding CanaFarma Hemp Products or generate 0.0% return on investment over 90 days. CanaFarma Hemp Products is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than CanaFarma, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
CanaFarma Hemp Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for CanaFarma Hemp's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as CanaFarma Hemp Products, and traders can use it to determine the average amount a CanaFarma Hemp's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| CNFHF |
Based on monthly moving average CanaFarma Hemp is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of CanaFarma Hemp by adding CanaFarma Hemp to a well-diversified portfolio.
CanaFarma Hemp Fundamentals Growth
CanaFarma Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of CanaFarma Hemp, and CanaFarma Hemp fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on CanaFarma Pink Sheet performance.
| Operating Margin | (17.98) % | |||
| Current Valuation | 254.66 K | |||
| Shares Outstanding | 195.61 M | |||
| Price To Sales | 10.01 X | |||
| Revenue | 1.8 M | |||
| EBITDA | (9.39 M) | |||
| Cash And Equivalents | 9.17 K | |||
| Total Debt | 244.27 K | |||
| Book Value Per Share | (0) X | |||
| Cash Flow From Operations | (5.99 M) | |||
| Earnings Per Share | (0.05) X | |||
| Total Asset | 6.76 M | |||
About CanaFarma Hemp Performance
By analyzing CanaFarma Hemp's fundamental ratios, stakeholders can gain valuable insights into CanaFarma Hemp's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if CanaFarma Hemp has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if CanaFarma Hemp has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
CanaFarma Hemp Products Corp. engages in growing, manufacturing, processing, and selling hemp oil in the United States. The company offers hemp-based products, such as chewing gum and tincture under the YOOFORIC brand. Canafarma Hemp is traded on OTC Exchange in the United States.Things to note about CanaFarma Hemp Products performance evaluation
Checking the ongoing alerts about CanaFarma Hemp for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for CanaFarma Hemp Products help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| CanaFarma Hemp generated a negative expected return over the last 90 days | |
| CanaFarma Hemp has some characteristics of a very speculative penny stock | |
| CanaFarma Hemp Products has accumulated 244.27 K in total debt. CanaFarma Hemp Products has a current ratio of 0.32, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist CanaFarma Hemp until it has trouble settling it off, either with new capital or with free cash flow. So, CanaFarma Hemp's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like CanaFarma Hemp Products sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for CanaFarma to invest in growth at high rates of return. When we think about CanaFarma Hemp's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 1.8 M. Net Loss for the year was (17.8 M) with loss before overhead, payroll, taxes, and interest of (2.32 M). | |
| CanaFarma Hemp Products has accumulated about 9.17 K in cash with (5.99 M) of positive cash flow from operations. | |
| Roughly 30.0% of the company shares are held by company insiders |
- Analyzing CanaFarma Hemp's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether CanaFarma Hemp's stock is overvalued or undervalued compared to its peers.
- Examining CanaFarma Hemp's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating CanaFarma Hemp's management team can have a significant impact on its success or failure. Reviewing the track record and experience of CanaFarma Hemp's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of CanaFarma Hemp's pink sheet. These opinions can provide insight into CanaFarma Hemp's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for CanaFarma Pink Sheet analysis
When running CanaFarma Hemp's price analysis, check to measure CanaFarma Hemp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CanaFarma Hemp is operating at the current time. Most of CanaFarma Hemp's value examination focuses on studying past and present price action to predict the probability of CanaFarma Hemp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CanaFarma Hemp's price. Additionally, you may evaluate how the addition of CanaFarma Hemp to your portfolios can decrease your overall portfolio volatility.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |